Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
Just before the November 4th AMDAC on solithromycin, we are being treated to a very fine piece of study write-up. Of course, we are speaking of the File paper on the SOLITAIRE-IV trial, and what a fine piece of crafty penmanship it is, if you haven’t noticed. Just as a Continue reading Solithromycin SOLITAIRE-IV: So-So Results for a So-So Drug
Searching data on antibiotic use in surgery prophylaxis, I came across an article from the Mayo Clinic [1]. The authors mention that approx. 75% of patients that developed surgical site infections did not get proper antibiotic prophylaxis. Errors were made in (1) selection of the antibiotic, (2) timing of administration, (3) antibiotic Continue reading No Easy Day: Dose Calculations for Aminoglycosides and Vancomycin